Kestra Advisory Services, LLC Summit Therapeutics Inc. Transaction History
Kestra Advisory Services, LLC
- $17.2 Billion
- Q4 2024
A detailed history of Kestra Advisory Services, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 39,218 shares of SMMT stock, worth $771,810. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,218
Previous 39,218
-0.0%
Holding current value
$771,810
Previous $858,000
18.41%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
233Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$481 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$230 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$155 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$129 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$110 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.96B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...